Serena Williams may just be gearing up for one of the most unexpected comebacks in modern sports. After years of leaving fans wondering whether her farewell was final, the 23-time Grand Slam champion has quietly taken the first bureaucratic step toward returning to competitive tennis—rejoining the International Tennis Integrity Agency’s (ITIA) registered drug-testing pool for the first time since 2022. But here’s where it gets intriguing: signing up for testing doesn’t confirm she’s coming back, yet it undeniably opens the door.
At 44, Williams last competed more than three years ago, during her memorable run to the third round of the 2022 US Open. Back then, she never used the word “retirement,” instead saying she was [quote] "evolving away" from tennis—a phrase that left hopeful fans clinging to the idea of a future return. Following that tournament, she formally exited the sport’s testing system by filing ITIA paperwork exempting her from its strict whereabouts requirements, which every active player must follow. Now, by rejoining the testing pool, Williams restarts a mandatory six-month eligibility clock: she must remain available for random drug tests before she can officially enter another event.
Her name appeared on the ITIA’s updated list dated October 6, confirming her reinstatement request. Still, the agency cautioned that inclusion isn’t proof of intent—some players join the pool to keep their options open. Williams’s representatives have not commented on her motives, leaving room for speculation and excitement alike.
Interestingly, the ITIA registered pool isn’t where every professional resides; it’s designed for top-ranked singles players, active doubles specialists, wheelchair athletes at the elite level, and those returning from extended breaks—exactly the category Williams fits. That exclusivity only fuels buzz about what she might be planning.
Rumors of a surprise appearance swirled during this year’s US Open, especially in the mixed doubles draw, which has evolved into a celebrity-studded mini-event. Some insiders believe Serena had explored an even earlier re-entry in August, aiming for a nostalgic doubles team-up with sister Venus Williams. However, that plan fell apart when the strict six-month testing requirement proved non-negotiable—a rule that once dashed Andy Roddick’s cameo hopes back in 2014.
Venus, meanwhile, continues to defy expectations on her own path. Unlike Serena, she never officially retired, sparing herself the procedural hurdles. The 45-year-old returned this summer after a 16-month hiatus, earning a singles victory in Washington, pushing world No. 11 Karolína Muchová to a third set in New York, and reaching the US Open doubles quarterfinals with Leylah Fernandez. Her resurgence adds an intriguing layer: could tennis fans soon witness a Williams sister reunion on court once more?
For now, Serena’s reappearance in ITIA documents doesn’t necessarily mean an official comeback — but it reignites hope. If she stays in the testing pool uninterrupted, she could be eligible to compete by mid-2026. Whether she returns as a singles powerhouse, pairs again with Venus, or simply keeps the door open remains a mystery. And here’s the part that divides fans and experts alike: should an athlete of her legacy and accomplishments return for one more chapter, or is her mythical exit best left untouched? What do you think—should Serena play again, or has she already done enough to etch her place in tennis history?
